Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
12.55
+1.21 (10.67%)
At close: Mar 9, 2026, 4:00 PM EDT
12.49
-0.06 (-0.48%)
After-hours: Mar 9, 2026, 7:08 PM EDT

Benitec Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21 2020 - 2016
Net Income
-44.11-37.92-21.75-19.56-18.21-13.88
Upgrade
Depreciation & Amortization
0.460.40.340.380.390.42
Upgrade
Loss (Gain) From Sale of Investments
--000.01-0.02
Upgrade
Stock-Based Compensation
26.4117.430.830.450.870.63
Upgrade
Other Operating Activities
--0.76----
Upgrade
Change in Accounts Receivable
0.120.2-0.18-0.0500.03
Upgrade
Change in Accounts Payable
-0.57-2.380.941.361.090.06
Upgrade
Change in Other Net Operating Assets
-0.74-0.550.41-0.59-0.05-0.08
Upgrade
Operating Cash Flow
-18.43-23.59-19.4-18.01-15.9-12.83
Upgrade
Capital Expenditures
-0.02-0.02-0.18-0-0.01-0.22
Upgrade
Investing Cash Flow
-0.02-0.02-0.18-0-0.01-0.22
Upgrade
Issuance of Common Stock
137.7772.873.9217.88-25.75
Upgrade
Other Financing Activities
-8.58-2.32-5.89-1.87--3.23
Upgrade
Financing Cash Flow
129.1970.4968.0316.02-22.52
Upgrade
Foreign Exchange Rate Adjustments
-0.190.05-0.010.410.20.5
Upgrade
Net Cash Flow
110.5646.9348.44-1.59-15.719.97
Upgrade
Free Cash Flow
-18.44-23.61-19.58-18.01-15.91-13.05
Upgrade
Free Cash Flow Margin
----24017.33%-21797.26%-22123.73%
Upgrade
Free Cash Flow Per Share
-0.44-0.65-1.07-13.00-33.10-51.66
Upgrade
Levered Free Cash Flow
-4.36-11.46-11.68-10.19-8.72-7.28
Upgrade
Unlevered Free Cash Flow
-4.36-11.46-11.68-10.16-8.7-7.28
Upgrade
Change in Working Capital
-1.19-2.731.170.711.040.01
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.